LAPCOS SUNTIAGING EYE ZONE COOLING GOLF PAT CH S

Manufacturer
JC FAMILY Co., Ltd | Kovas Co., Ltd.
Effective date
2022-09-02
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
legacy-cache
Hydrated at
2026-08-01 21:54:34

Label at a glance#

ProductLAPCOS SUNTIAGING EYE ZONE COOLING GOLF PAT CH S
Active ingredientNiacinamide, Adenosine
Label structure10 sections

Indications and uses

■ Helps brighten skin tone ■ Helps improve wrinkle problem

Dosage and administration

■. Open the product to take out the patch. Remove the protection. ■. Place the patch on the under-eye, cheekbone, cheek and other areas. ■. Leave it for 30 minutes before removing. ■. You can also use it for longer time during outdoor activities. Also suitable to use on top of sunscreen or makeup. The patch may become less adhesive when used on oily skin.

Label contents#

Full prescribing information#

ACTIVE INGREDIENT

OTC - ACTIVE INGREDIENT SECTION

Niacinamide 2.0%
Adenosine 0.04%

INACTIVE INGREDIENTS

INACTIVE INGREDIENT SECTION

Water/Aqua, Glycerin, Dipropylene Glycol, Dipropylene Glycol, Polyacrylic Acid, Agar, Sodium Polyacrylete, Hydrocyacetophenone, Xanthan Gum, Caprylyl Glycol, Cellulose Gum, Disodium EDTA, Tartaric Acid, Cetyl Ethylhexanoate, Caprylyl/Capryl Glucoside, Butylene Glycol, Menthyl Lactate, Aluminum Glycinate, Panthenol, Sodium Hyaluronate, 1,2-Hexanediol, Centella Asiatica Extract, Hydrolyzed Collagen, Dipotassium Glycyrrhizate, Arbutin, Houttuynia Cordata Extract, Alpha-Arbutin, Glutathione, Ascorbic Acid, Madecassoside, Polyglyceryl-10 Laurate,Palmitoyl Pentapeptide-4, Palmitoyl Tripeptide-1, Hexapeptide-9, Aceytl Hexapeptide-8, Tripeptide-1, Copper Tripeptide-1

PURPOSE

OTC - PURPOSE SECTION

Skin Brightening
Anti wrinkle

WARNINGS

WARNINGS SECTION

For external use only
Discontinue use if signs of irritation or rashes appear.
Keep out of reach of children

KEEP OUT OF REACH OF CHILDREN

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

KEEP OUT OF REACH OF CHILDREN

Uses

INDICATIONS & USAGE SECTION

■ Helps brighten skin tone
■ Helps improve wrinkle problem

Directions

DOSAGE & ADMINISTRATION SECTION

■. Open the product to take out the patch. Remove the protection.
■. Place the patch on the under-eye, cheekbone, cheek and other areas.
■. Leave it for 30 minutes before removing.
■. You can also use it for longer time during outdoor activities. Also suitable to use on top of sunscreen or makeup. The patch may become less adhesive when used on oily skin.

Image of directionsImage of directions

Other Information

OTHER SAFETY INFORMATION

■ Please put the patches on before applying the sunscreen when planning for heavy exercise.
■The back film of the patch may hang when opened.
■ Do not store this product in an inappropriate place such as high or low temperatures or under direct sun light

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Image of cartonImage of carton

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
82971-010-012024-11-24C16284748780-11030e365-29c4-111a-e063-dadaa90a10e2c82a3500-06e8-46ca-9286-dd127a610665
82971-010-012024-01-30C16284748780-11030e365-29c4-111a-e063-dadaa90a10e2c82a3500-06e8-46ca-9286-dd127a610665

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
82971-01082971-010-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 5 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
27b3747d-48bb-fe3d-e063-6394a90a548ac82a3500-06e8-46ca-9286-dd127a6106652024-11-24WarningsExact identifier
spl set id: c82a3500-06e8-46ca-9286-dd127a610665

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.